173 related articles for article (PubMed ID: 1679417)
1. Heterogeneity of thyrotropin binding inhibitor immunoglobulins in serum from untreated patients with hyperthyroid Graves' disease.
Lu C; Kasagi K; Iida Y; Konishi J
Immunol Lett; 1991 Jun; 28(3):233-6. PubMed ID: 1679417
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
Morris JC; Hay ID; Nelson RE; Jiang NS
Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
[TBL] [Abstract][Full Text] [Related]
5. A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs.
Kawai K; Tamai H; Matsubayashi S; Mukuta T; Morita T; Kubo C; Kuma K
Clin Endocrinol (Oxf); 1995 Nov; 43(5):551-6. PubMed ID: 8548939
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.
Cho BY; Shong MH; Yi KH; Lee HK; Koh CS; Min HK
Clin Endocrinol (Oxf); 1992 Jun; 36(6):585-90. PubMed ID: 1358483
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. I. A sensitive assay for thyroid-stimulating antibodies using cultured porcine thyroid cells and polyethylene glycol precipitation of serum].
Uno C; Nishikawa M
Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):193-205. PubMed ID: 2899523
[TBL] [Abstract][Full Text] [Related]
9. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
Mori Y; Matoba N; Miura S; Sakai N; Taira Y
World J Surg; 1992; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
[TBL] [Abstract][Full Text] [Related]
11. Changes in thyrotropin receptor antibody after subtotal thyroidectomy in Graves' disease: comparison with the degree of lymphocytic infiltration in the thyroid.
Cho BY; Oh SK; Shong YK; Kim SE; Yoo HY; Lee HK; Koh CS; Min HK
Autoimmunity; 1990; 8(2):143-7. PubMed ID: 1983330
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
13. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
Leedman PJ; Frauman AG; Colman PG; Michelangeli VP
Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
[TBL] [Abstract][Full Text] [Related]
14. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
[TBL] [Abstract][Full Text] [Related]
16. Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin.
Mukuta T; Tamai H; Oshima A; Morita T; Matsubayashi S; Fukata S; Kuma K
Clin Endocrinol (Oxf); 1994 Feb; 40(2):215-9. PubMed ID: 7907955
[TBL] [Abstract][Full Text] [Related]
17. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of thyroid-stimulating antibody measurement using Chinese hamster ovary cells expressing human thyrotropin receptors.
Murakami M; Miyashita K; Kakizaki S; Saito S; Yamada M; Iriuchijima T; Takeuchi T; Mori M
Eur J Endocrinol; 1995 Jul; 133(1):80-6. PubMed ID: 7627342
[TBL] [Abstract][Full Text] [Related]
19. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Graves' disease (author's transl)].
Endo K
Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1261-74. PubMed ID: 228998
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
Ochi Y; Hamazu M; Kajita Y; Nagata A
Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]